Health

PD-1 Inhibitor Raises PFS in Advanced Acral Melanoma

TribeNews
By TribeNews 19 Views Add a Comment
0 Min Read
PD-1 Inhibitor Raises PFS in Advanced Acral Melanoma

MedPage Today) ā€” First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but statistically significant increase in progression-free survival (PFS) compared with treatment with dacarbazineā€¦

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app